Adrenal hemorrhage MRI

Adrenal hemorrhage Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adrenal hemorrhage from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adrenal hemorrhage MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adrenal hemorrhage MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adrenal hemorrhage MRI
CDC on Adrenal hemorrhage MRI
Adrenal hemorrhage MRI in the news
Blogs on Adrenal hemorrhage MRI
Directions to Hospitals Treating Adrenal hemorrhage
Risk calculators and risk factors for Adrenal hemorrhage MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Magnetic Resonance Imaging

• Acute stage (less than 7 days after onset): the hematoma typically appears isointense or slightly hypointense on T1-weighted images and markedly hypointense on T2-weighted images.
• Subacute stage (7 days to 7 weeks after onset): the hematoma appears hyperintense on T1- and T2-weighted images.
• Chronic stage (which typically begins 7 weeks after onset): a hypointense rim is present on T1- and T2-weighted images, which is attributed to hemosiderin deposition and the presence of a fibrous capsule.